Examples of using Beta-agonists in English and their translations into German
{-}
-
Official
-
Medicine
-
Colloquial
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
In high dosages beta-agonists promote the formation of muscle mass.
Subjects on fingolimod treatment have a normal bronchodilator response to inhaled beta-agonists.
Beta-Agonists are currently authorised for therapeutic use in animals in most Member States.
Serious reactions have been treatedsuccessfully with supportive therapy such as oxygen, beta-agonists, and corticosteroids.
In general, beta-agonists can mimic the effects of catecholamines on the immune system.
Mafia-type organisations give our cattle hormones, antibiotics, corticosteroids,betablockers, and beta-agonists.
Ii beta-agonists, in the form of an injection to induce tocolysis in cows when calving.
Parliament resolution on the Commission communicationon control of residues in meat: hormones, beta-agonists and other substances.
Veterinary medicinal products containing beta-agonists which have a withdrawal period of more than 28 days after the end of treatment.
Reference: Commission communication to the Counciland to Parliament on control of residues in meat: hormones, beta-agonists and other substances: COM(93) 167; Bull.
Substances with a hormonal or thyrostatic action and beta-agonists as growth promoters in beef production have long-term effects and may therefore have repercussions on human health.
Beta-adrenergic receptor blocking agents are able to produce severe bronchospasm in patients with asthma andinteract block the pulmonary effect of beta-agonists Ventolin.
Hormonal products and beta-agonists the administration of which to farm animals is authorized in accordance with Articles 4 and 5 must meet the requirements of Directives 81/851/EEC and 81/852/EEC.
In writing.-(PT) The Commission proposes to exclude pet animals from the scope of Council Directive 96/22/EC which would enable theirtreatment with substances having a thyrostatic action and with beta-agonists.
Pending application of the provisions of this Directive as regards beta-agonists, the relevant national rules shall continue to apply in compliance with the general provisions of the Treaty.
Whereas by Directive 96/22/EC(4) the Council decided to maintain the prohibition on the use of certain substances having a hormonal or thyrostatic action,by extending it to beta-agonists having an anabolic effect;
It belongs to a category of compounds known as beta-agonists that bind to beta-adrenergic receptors deposited in the cell membrane- they serve cellular signaling, break down fat and activate growth in muscle cells.
Proposal for a European Parliament and Council Directive amending Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain substances having a hormonal orthyrostatic action and of beta-agonists.
Reflecting transport costs as well as thecosts for not applying growth hormones and beta-agonists, which are forbidden in the EU, would take the US-costs to a level which is slightly higher than the prices received by most typical EU farms in 2012.
Thirdly, with regard to the assessment as to whether the measures in question are necessary and whether alternative less restrictive measures may exist, it should first beremembered that the provisional MRLs were fixed for beta-agonists, and in particular for clenbuterol, by Regulation No 1312/96.
The applicants claim to account for'almost 97% of the sales of the veterinary medicinal products affected by the prohibition of beta-agonists' provided for in Council Directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stockfarming of certain substances havinga hormonal or thyrostatic action and of beta-agonists, and repealing Directives 81/602/EEC, 88/146/EEC and 88/299/EEC OJ 1996 L 125.
The results of these studies showed that, although it had not been proven that the use of"natural" hormones under very specific conditions presented risks to human health,the same could not be said of other hormones and beta-agonists, which called for further close examination.
Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain substanceshaving a hormonal or thyrostatic action and of beta-agonists and repealing Directive 81/602/EEC, 88/146/EEC and 88/229/EEC7 prohibits the use of certain substances for specific purposes in food-producing animals.
Common position of the Council on the adoption of a Directive of the European Parliament and of the Council amending Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain substances having a hormonal orthyreostatic action and of beta-agonists.
Whereas withdrawal periods are not harmonized at Community level and there are considerable differences between Member States, particularly as regards authorized veterinarymedicinal products containing hormonal substances or beta-agonists; whereas, in the interests of harmonization, maximum withdrawal periods should therefore be set for such medicinal products;
Section Opinion on the Proposal for a Directive of the European Parliament and of the Council amending Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain substances having a hormonal orthyrostatic action and of beta-agonists.
Following the amendment of Council Directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stockfarming of certain substances having a hormonal orthyrostatic action and of beta-agonists by Directive 2003/74/EC of the European Parliament and of the Council of 22 September 2003 the Community brought itself into compliance with the DSB rulings and recommendations.
Whereas the improper use of beta-agonists can be a serious risk to human health; whereas, in the interests of the consumer, the holding, administering to animals of any species and the placing on the market for that purpose of beta-agonists should be prohibited; whereas, moreover, the holding, administering to animals of any species and the placing on the market of stilbenes and thyrostatic substances should be prohibited and the use of other substances regulated;
Recommendation for second reading(A5-0201/2003), on behalf of the Committee on the Environment, Public Health and Consumer Policy, on the Council common position for adopting a European Parliament and Council directive amending Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain substances having a hormonal orthyrostatic action and of beta-agonists(14502/1/2002- C5-0079/2003- 2001/0132(COD)) Rapporteur: Mr Olsson.
Meat or products from animals to which substances having an oestrogenic,androgenic or gestagenic action or beta-agonists have been administered in accordance with the dispensatory provisions of this Directive may not be placed on the market for human consumption unless the animals in question have been treated with veterinary medicinal products complying with the requirements of Article 6 and in so far as the withdrawal period laid down was observed before the animals were slaughtered.